MX2024005658A - Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. - Google Patents
Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos.Info
- Publication number
- MX2024005658A MX2024005658A MX2024005658A MX2024005658A MX2024005658A MX 2024005658 A MX2024005658 A MX 2024005658A MX 2024005658 A MX2024005658 A MX 2024005658A MX 2024005658 A MX2024005658 A MX 2024005658A MX 2024005658 A MX2024005658 A MX 2024005658A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- protein tyrosine
- tyrosine phosphatase
- phosphatase inhibitors
- sup
- Prior art date
Links
- 239000003806 protein tyrosine phosphatase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278339P | 2021-11-11 | 2021-11-11 | |
| PCT/US2022/049584 WO2023086498A1 (en) | 2021-11-11 | 2022-11-10 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024005658A true MX2024005658A (es) | 2024-08-06 |
Family
ID=84689141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024005658A MX2024005658A (es) | 2021-11-11 | 2022-11-10 | Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250019374A1 (https=) |
| EP (1) | EP4430038A1 (https=) |
| JP (1) | JP2024543452A (https=) |
| CN (1) | CN118525016A (https=) |
| AU (1) | AU2022387106A1 (https=) |
| CA (1) | CA3236854A1 (https=) |
| MX (1) | MX2024005658A (https=) |
| WO (1) | WO2023086498A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20252789A1 (es) | 2023-05-24 | 2025-12-22 | Kumquat Biosciences Inc | Compuestos heterociclicos y usos de estos |
| WO2025026158A1 (zh) * | 2023-07-28 | 2025-02-06 | 杭州中美华东制药有限公司 | 具有ptpn2抑制作用的化合物及其用途 |
| WO2025242216A1 (zh) * | 2024-05-24 | 2025-11-27 | 杭州百新生物医药科技有限公司 | 吲哚啉类化合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA94921C2 (en) * | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| UA94724C2 (en) * | 2005-12-08 | 2011-06-10 | Новартис Аг | Thiadiazolidinone derivatives as antidiabetic agents |
| BR112020026086A2 (pt) * | 2018-06-21 | 2021-03-23 | Calico Life Sciences Llc | inibidores da proteína tirosina fosfatase e métodos de uso destes |
| IL286373B2 (en) * | 2019-03-14 | 2026-03-01 | Calico Life Sciences Llc | Protein tyrosine phosphate inhibitor compounds and uses thereof |
| CA3162069A1 (en) * | 2019-12-18 | 2021-06-24 | Elliot P. Farney | Protein tyrosine phosphatase inhibitors and methods of use thereof |
-
2022
- 2022-11-10 WO PCT/US2022/049584 patent/WO2023086498A1/en not_active Ceased
- 2022-11-10 JP JP2024527750A patent/JP2024543452A/ja active Pending
- 2022-11-10 MX MX2024005658A patent/MX2024005658A/es unknown
- 2022-11-10 CA CA3236854A patent/CA3236854A1/en active Pending
- 2022-11-10 AU AU2022387106A patent/AU2022387106A1/en active Pending
- 2022-11-10 US US18/709,214 patent/US20250019374A1/en active Pending
- 2022-11-10 CN CN202280088273.9A patent/CN118525016A/zh active Pending
- 2022-11-10 EP EP22834767.0A patent/EP4430038A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023086498A1 (en) | 2023-05-19 |
| AU2022387106A1 (en) | 2024-05-23 |
| CN118525016A (zh) | 2024-08-20 |
| EP4430038A1 (en) | 2024-09-18 |
| CA3236854A1 (en) | 2023-05-19 |
| US20250019374A1 (en) | 2025-01-16 |
| JP2024543452A (ja) | 2024-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024005658A (es) | Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. | |
| BR112021023136A2 (pt) | Compostos heterocíclicos, métodos de preparação e usos dos mesmos | |
| MX2021007833A (es) | Inhibidores aza-heterobiciclicos de mat2a y metodos de uso en el tratamiento de cancer. | |
| EA202191801A1 (ru) | Гетероциклические ингибиторы mat2a и способы применения для лечения рака | |
| MX2025004109A (es) | Inhibidores heterocíclicos de las proteínas mutantes kras g12c y utilizaciones de los mismos | |
| JOP20200315A1 (ar) | مركبات بورينون واستخدامها في معالجة السرطان | |
| CR20220234A (es) | Degradadores de moléculas pequeñas de helios y procedimientos de uso | |
| EA202092320A1 (ru) | Гетеробициклические ингибиторы mat2a и способы использования для лечения злокачественной опухоли | |
| MX2023004802A (es) | Compuestos espiro heterocíclicos y métodos de uso. | |
| EA200300248A1 (ru) | Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции | |
| EA201691142A1 (ru) | Ингибиторы мек и способы их применения | |
| EP3693369A3 (en) | Bromodomain inhibitors | |
| EA200400006A1 (ru) | Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов | |
| MX2025015186A (es) | Inhibidores de pi3k y uso de estos | |
| MX2022001151A (es) | Inhibidores deuterados de la via mk2 y metodos de uso de los mismos. | |
| EA200500299A1 (ru) | Пиразольные композиции, используемые в качестве ингибиторов gsk-3 | |
| ATE473980T1 (de) | Triazolopyridazine als proteinkinase-inhibitoren | |
| JOP20240250A1 (ar) | مركبات واستخداماتها | |
| ZA202304734B (en) | Alpha protein kinase 1 inhibitors and methods of use | |
| ATE493418T1 (de) | Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren | |
| PH12021551304A1 (en) | Tyrosine kinase inhibitors, compositions and methods there of | |
| MX2023009379A (es) | Derivados de tetrahidroazepina biciclicos para el tratamiento del cancer. | |
| MX2022011194A (es) | Bloqueadores de canales ionicos cargados y metodos de uso. | |
| MX2023011408A (es) | Compuestos de oxoisoindolina sustituidos con piridinilo para el tratamiento de cancer. | |
| MX2021010869A (es) | Bloqueadores de canales iónicos sustituidos por éster y métodos para su uso. |